Jean-Claude L.
- Country
- France
- Department
- Service de soins intensifs
Research Overview
- Evaluation of AON-D21 Efficacy and Safety in Severe Community-Acquired Pneumonia: A Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of Recombinant Human Plasma Gelsolin in Moderate-to-Severe Acute Respiratory Distress Syndrome Due to Pneumonia or Other Infections
- Evaluation of Hydrocortisone and Fludrocortisone Efficacy in Critically Ill Patients with Corticosteroid Insufficiency: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 15 of 82 partner sites.
Specializations
Respiratory Infections
Specializes in the treatment of severe community-acquired pneumonia, particularly focusing on patients requiring intensive care intervention. The investigator's work encompasses innovative therapeutic approaches for managing severe respiratory infections.
- Critical Care Management
- Pneumonia Treatment Protocols
- Intensive Care Medicine
Acute Respiratory Conditions
Conducts research in the treatment of Acute Respiratory Distress Syndrome (ARDS), with particular emphasis on cases caused by pneumonia and other infectious agents. The investigator explores novel therapeutic interventions using plasma proteins.
- ARDS Management
- Plasma Protein Therapeutics
- Infectious Disease Complications
Critical Care Endocrinology
Focuses on critical illness-related corticosteroid insufficiency in intensive care settings. The investigator studies hormonal interventions for critically ill patients, particularly examining the role of corticosteroid therapy in improving patient outcomes.
- Corticosteroid Therapy
- Ventilator Management
- Critical Care Outcomes
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.